BlackRock, Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2012383 New York, NY

Position in VRTX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$11,975,848,839

+$1,272,500,727 QoQ

Shares Held

24,109,373

+0.6% QoQ

Ownership

9.51%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

of 1,732 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $85,016,936,299 across 474 Biotechnology names. VRTX ranks #1 (14.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	24,109,373	$11,975,848,839
2	REGN	Regeneron Pharmaceuticals, Inc.	9,113,506	$5,682,635,520
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,907,675	$3,283,537,392
4	RVMD	Revolution Medicines, Inc.	13,695,790	$2,564,947,540
5	MRNA	Moderna, Inc.	30,599,409	$2,142,876,602
6	INCY	Incyte Corp	18,032,718	$2,044,188,902
7	CYTK	Cytokinetics Inc	20,094,362	$1,711,838,691
8	ROIV	Roivant Sciences Ltd.	48,236,091	$1,707,075,250

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,975,848,839	24,109,373	+0.6%	Shares	Sole	2026-08-07
2026-03-31	$10,703,348,112	23,969,517	+0.9%	Shares	Sole	2026-05-13
2025-12-31	$10,768,201,720	23,751,989	+6.7%	Shares	Sole	2026-02-12
2025-09-30	$8,715,183,315	22,253,047	+1.7%	Shares	Sole	2025-11-12
2025-06-30	$9,737,389,907	21,871,945	+0.4%	Shares	Sole	2025-08-12
2025-03-31	$10,560,801,565	21,782,933	-0.2%	Shares	Sole	2025-05-02
2024-12-31	$8,789,116,759	21,825,470	+0.2%	Shares	Sole	2025-02-07
2024-09-30	$10,132,951,882	21,787,546	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.